{
  "title": "An 'Analog' Process Needing a Digital Intelligence Upgrade",
  "subtitle": "Clinical trials are plagued by inefficiencies that cost billions and delay life-saving treatments",
  "cards": [
    {
      "number": "01",
      "title": "Slow",
      "description": "Manual iteration and resource-intensive workload. Critical data buried in massive information volumes."
    },
    {
      "number": "02", 
      "title": "Costly",
      "description": "Average cost to get a drug to market: $2.6B. Delays cost millions (Avg $40K/day in Phase 3)."
    },
    {
      "number": "03",
      "title": "Opaque",
      "description": "Black-box decision making without audit trails. Volume of information means research isn't exhaustive."
    },
    {
      "number": "04",
      "title": "Risky",
      "description": "Bias leading to regulatory and commercial failures. Design complexity causes failures and delays."
    },
    {
      "number": "05",
      "title": "Siloed",
      "description": "Complex workflows that don't engage ALL stakeholders lead to designs that can't be executed."
    }
  ]
} 